RGEN Key Stats
- Nasdaq stocks posting largest percentage increases May 13
- Repligen Stock Sees Short Interest Move 24.7% Higher May 10
- REPLIGEN CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Ho... May 10
- Stocks Hitting 52-Week Highs Benzinga May 8
- REPLIGEN CORP Files SEC form 10-Q, Quarterly Report May 7
- Repligen's CEO Discusses Q1 2013 Results - Earnings Call Transcript Seeking Alpha May 3
- Repligen Reports First Quarter 2013 Financial Results noodls May 2
- Repligen Corporation Earnings Call scheduled for 9:00 am ET today May 2
- Repligen Corp (RGEN) Reports Q1 EPS of $0.07; Guides FY13 Street Insider May 2
- InPlay: Repligen reports Q1 results, revs rose 28% YoY to $16.5 mln, provides gu... May 2
RGEN Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Repligen Corporation is up 92.41% over the last year vs S&P 500 Total Return up 31.63%, Targacept up 35.19%, and Isis Pharmaceuticals up 129.1%.
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Pro Ratings for RGEN
Pro Report PDF for RGEN
Download Pro Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.Download RGEN Pro Report PDF
Pro Strategies Featuring RGEN
Did Repligen Corporation make it into our Pro Portfolio Strategies?